Learn More
Medchemexpress LLC N-cyclopropyl-2,4-difluoro-5-((2-(pyridin-2-ylamino)thiazol-5-ylmethyl)amino)benzamide | 639858-32-5 | 99.6% | 100 MG

Supplier: Medchemexpress LLC HY120640100MG
BMS-605541 is a selective, orally active VEGFR-2 kinase inhibitor used in cancer research. It demonstrates potent inhibition of VEGFR-2 and measurable activity against VEGFR-1 and PDGFR-β.
- Selective VEGFR-2 (Flk-1) inhibition with low nanomolar potency.
- Demonstrated activity against VEGFR-1 and PDGFR-β for pathway studies.
- High purity (99.6%) suitable for in vitro and cellular research.
- Available in multiple solid pack sizes and as a 10 mM solution in DMSO.
- Commonly used in cancer research and VEGF/PDGF signaling studies.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.